发明名称 |
PHARMACEUTICALLY ACTIVE COMPOUNDS |
摘要 |
The present invention relates to compounds of formula I: wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt or solvate thereof. The compounds of formula I are inhibitors of aurora kinase and/or FLT3. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which aurora kinase and/or FLT3 activity is implicated. |
申请公布号 |
WO2013190319(A1) |
申请公布日期 |
2013.12.27 |
申请号 |
WO2013GB51633 |
申请日期 |
2013.06.21 |
申请人 |
CANCER RESEARCH TECHNOLOGY LIMITED |
发明人 |
BLAGG, JULIAN;BAVETSIAS, VASSILIOS;MOORE, ANDREW S.;LINARDOPOULOS, SPYRIDON |
分类号 |
C07D471/06;A61K31/437;A61P35/00 |
主分类号 |
C07D471/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|